Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

The Importance of the Autopsy in Medicine: Perspectives of Pathology Colleagues.

Buja LM, Barth RF, Krueger GR, Brodsky SV, Hunter RL.

Acad Pathol. 2019 Mar 10;6:2374289519834041. doi: 10.1177/2374289519834041. eCollection 2019 Jan-Dec. Review.

2.

What did Joseph Stalin really die of? A reappraisal of his illness, death, and autopsy findings.

Barth RF, Brodsky SV, Ruzic M.

Cardiovasc Pathol. 2019 May - Jun;40:55-58. doi: 10.1016/j.carpath.2019.02.003. Epub 2019 Feb 20. Review.

PMID:
30870795
3.

Genomic Analysis of an Obesity Paradox: A Microarray Study of the Aortas of Morbidly Obese Decedents With Mild and Severe Atherosclerosis.

Brodsky SV, Ganju R, Mishra S, Ivanov I, Fadda P, Wang H, Barth RF.

Crit Pathw Cardiol. 2019 Mar;18(1):57-60. doi: 10.1097/HPC.0000000000000169.

PMID:
30747767
4.

A realistic appraisal of boron neutron capture therapy as a cancer treatment modality.

Barth RF, Zhang Z, Liu T.

Cancer Commun (Lond). 2018 Jun 19;38(1):36. doi: 10.1186/s40880-018-0280-5.

5.

Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget's disease with curative responses.

Hiratsuka J, Kamitani N, Tanaka R, Yoden E, Tokiya R, Suzuki M, Barth RF, Ono K.

Cancer Commun (Lond). 2018 Jun 19;38(1):38. doi: 10.1186/s40880-018-0297-9.

6.

Boron delivery agents for neutron capture therapy of cancer.

Barth RF, Mi P, Yang W.

Cancer Commun (Lond). 2018 Jun 19;38(1):35. doi: 10.1186/s40880-018-0299-7. Review.

7.

Assessment of atherosclerotic luminal narrowing of coronary arteries based on morphometrically generated visual guides.

Barth RF, Kellough DA, Allenby P, Blower LE, Hammond SH, Allenby GM, Buja LM.

Cardiovasc Pathol. 2017 Jul - Aug;29:53-60. doi: 10.1016/j.carpath.2017.05.005. Epub 2017 May 30.

PMID:
28622581
8.

An Obesity Paradox: Increased Body Mass Index Is Associated with Decreased Aortic Atherosclerosis.

Barth RF, Maximilian Buja L, Cao L, Brodsky SV.

Curr Hypertens Rep. 2017 Jul;19(7):55. doi: 10.1007/s11906-017-0753-y. Review.

PMID:
28593612
9.

Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma.

Kondo N, Barth RF, Miyatake SI, Kawabata S, Suzuki M, Ono K, Lehman NL.

J Neurooncol. 2017 May;133(1):107-118. doi: 10.1007/s11060-017-2408-x. Epub 2017 May 22.

10.

An obesity paradox: an inverse correlation between body mass index and atherosclerosis of the aorta.

Brodsky SV, Barth RF, Mo X, Yildiz V, Allenby P, Ivanov I, Moore S, Hitchcock CL, Smith S, Sachak T, Yao K, Ball M, Rosborough K, Olson Z, Kiehl M, Muni N, Virmani R.

Cardiovasc Pathol. 2016 Nov - Dec;25(6):515-520. doi: 10.1016/j.carpath.2016.09.002. Epub 2016 Sep 13.

PMID:
27683962
11.

What did Sun Yat-sen really die of? A re-assessment of his illness and the cause of his death.

Barth RF, Chen J.

Chin J Cancer. 2016 Sep 2;35(1):81. doi: 10.1186/s40880-016-0144-9.

12.

Morphometric data on severely and morbidly obese deceased, established on forensic and non-forensic autopsies.

Brodsky SV, Gruszecki AC, Fallon K, Pasquale-Styles MA, Shaddy S, Yildiz V, Long SK, MacDonell M, Brideau RL, Keane J, Allenby P, Ivanov I, Moore S, Smith SM, Sachak T, Ball M, Yao K, James I, Muni N, Barth RF.

Virchows Arch. 2016 Oct;469(4):451-8. doi: 10.1007/s00428-016-1994-x. Epub 2016 Aug 2.

PMID:
27480641
13.

Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors.

Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B.

Onco Targets Ther. 2016 May 10;9:2769-81. doi: 10.2147/OTT.S99242. eCollection 2016.

14.

Quantitative imaging of magnesium distribution at single-cell resolution in brain tumors and infiltrating tumor cells with secondary ion mass spectrometry (SIMS).

Chandra S, Parker DJ, Barth RF, Pannullo SC.

J Neurooncol. 2016 Mar;127(1):33-41. doi: 10.1007/s11060-015-2022-8. Epub 2015 Dec 24.

15.

Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors.

Barth RF, Yang W, Nakkula RJ, Byun Y, Tjarks W, Wu LC, Binns PJ, Riley KJ.

Appl Radiat Isot. 2015 Dec;106:251-5. doi: 10.1016/j.apradiso.2015.06.031. Epub 2015 Jul 2.

16.

From the laboratory to the clinic: How translational studies in animals have lead to clinical advances in boron neutron capture therapy.

Barth RF.

Appl Radiat Isot. 2015 Dec;106:22-8. doi: 10.1016/j.apradiso.2015.06.016. Epub 2015 Jun 18.

PMID:
26149807
17.

Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer.

Agarwal HK, Khalil A, Ishita K, Yang W, Nakkula RJ, Wu LC, Ali T, Tiwari R, Byun Y, Barth RF, Tjarks W.

Eur J Med Chem. 2015 Jul 15;100:197-209. doi: 10.1016/j.ejmech.2015.05.042. Epub 2015 May 27.

18.

Gadolinium nanoparticles and contrast agent as radiation sensitizers.

Taupin F, Flaender M, Delorme R, Brochard T, Mayol JF, Arnaud J, Perriat P, Sancey L, Lux F, Barth RF, Carrière M, Ravanat JL, Elleaume H.

Phys Med Biol. 2015 Jun 7;60(11):4449-64. doi: 10.1088/0031-9155/60/11/4449. Epub 2015 May 19.

PMID:
25988839
19.

Tumoricidal activity of low-energy 160-KV versus 6-MV X-rays against platinum-sensitized F98 glioma cells.

Lim SN, Pradhan AK, Barth RF, Nahar SN, Nakkula RJ, Yang W, Palmer AM, Turro C, Weldon M, Bell EH, Mo X.

J Radiat Res. 2015 Jan;56(1):77-89. doi: 10.1093/jrr/rru084. Epub 2014 Sep 28.

21.

Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma.

Zhang H, Zhong H, Barth RF, Cao M, Das IJ.

Med Phys. 2014 Feb;41(2):021727. doi: 10.1118/1.4862837.

PMID:
24506618
22.

Effects of l-DOPA pre-loading on the uptake of boronophenylalanine using the F98 glioma and B16 melanoma models.

Yang W, Barth RF, Huo T, Kabalka GW, Shaikh AL, Haider SA, Chandra S.

Appl Radiat Isot. 2014 Jun;88:69-73. doi: 10.1016/j.apradiso.2014.01.002. Epub 2014 Jan 15.

23.

Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors.

Yang W, Barth RF, Huo T, Nakkula RJ, Weldon M, Gupta N, Agius L, Grecula JC.

Radiat Oncol. 2014 Jan 14;9:25. doi: 10.1186/1748-717X-9-25.

24.

Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas.

Barth RF, Kabalka GW, Yang W, Huo T, Nakkula RJ, Shaikh AL, Haider SA, Chandra S.

Appl Radiat Isot. 2014 Jun;88:38-42. doi: 10.1016/j.apradiso.2013.11.133. Epub 2013 Dec 12.

25.

Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas.

Chandra S, Barth RF, Haider SA, Yang W, Huo T, Shaikh AL, Kabalka GW.

PLoS One. 2013 Sep 18;8(9):e75377. doi: 10.1371/journal.pone.0075377. eCollection 2013.

26.

Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy.

Sjuvarsson E, Damaraju VL, Mowles D, Sawyer MB, Tiwari R, Agarwal HK, Khalil A, Hasabelnaby S, Goudah A, Nakkula RJ, Barth RF, Cass CE, Eriksson S, Tjarks W.

J Pharmacol Exp Ther. 2013 Nov;347(2):388-97. doi: 10.1124/jpet.113.207464. Epub 2013 Sep 4.

27.

Unique in vitro and in vivo thrombopoietic activities of ingenol 3,20 dibenzoate, a Ca(++)-independent protein kinase C isoform agonist.

Racke FK, Baird M, Barth RF, Huo T, Yang W, Gupta N, Weldon M, Rutledge H.

PLoS One. 2012;7(12):e51059. doi: 10.1371/journal.pone.0051059. Epub 2012 Dec 21.

28.

Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.

Huo T, Barth RF, Yang W, Nakkula RJ, Koynova R, Tenchov B, Chaudhury AR, Agius L, Boulikas T, Elleaume H, Lee RJ.

PLoS One. 2012;7(11):e48752. doi: 10.1371/journal.pone.0048752. Epub 2012 Nov 13.

29.

Intracerebral delivery of carboplatin in combination with either 6 MV photons or monoenergetic synchrotron X-rays are equally efficacious for treatment of the F98 rat glioma.

Bobyk L, Edouard M, Deman P, Rousseau J, Adam JF, Ravanat JL, Estève F, Balosso J, Barth RF, Elleaume H.

J Exp Clin Cancer Res. 2012 Sep 20;31:78. doi: 10.1186/1756-9966-31-78.

30.

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.

Barth RF, Vicente MG, Harling OK, Kiger WS 3rd, Riley KJ, Binns PJ, Wagner FM, Suzuki M, Aihara T, Kato I, Kawabata S.

Radiat Oncol. 2012 Aug 29;7:146. doi: 10.1186/1748-717X-7-146. Review.

31.

Synthesis, biological evaluation, and radioiodination of halogenated closo-carboranylthymidine analogues.

Tiwari R, Toppino A, Agarwal HK, Huo T, Byun Y, Gallucci J, Hasabelnaby S, Khalil A, Goudah A, Baiocchi RA, Darby MV, Barth RF, Tjarks W.

Inorg Chem. 2012 Jan 2;51(1):629-39. doi: 10.1021/ic202150b. Epub 2011 Dec 16.

32.

Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of the F98 rat glioma.

Barth RF, Yang W, Huo T, Riley KJ, Binns PJ, Grecula JC, Gupta N, Rousseau J, Elleaume H.

Appl Radiat Isot. 2011 Dec;69(12):1813-6. doi: 10.1016/j.apradiso.2011.03.019. Epub 2011 Mar 21.

PMID:
21493080
33.

Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy.

Kabalka GW, Shaikh AL, Barth RF, Huo T, Yang W, Gordnier PM, Chandra S.

Appl Radiat Isot. 2011 Dec;69(12):1778-81. doi: 10.1016/j.apradiso.2011.03.035. Epub 2011 Mar 31.

34.

Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors.

Kawabata S, Yang W, Barth RF, Wu G, Huo T, Binns PJ, Riley KJ, Ongayi O, Gottumukkala V, Vicente MG.

J Neurooncol. 2011 Jun;103(2):175-85. doi: 10.1007/s11060-010-0376-5. Epub 2010 Sep 17.

35.

Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors.

Yang W, Huo T, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou TC, Rousseau J, Elleaume H.

J Neurooncol. 2011 Feb;101(3):379-90. doi: 10.1007/s11060-010-0272-z. Epub 2010 Jun 25. Erratum in: J Neurooncol. 2011 Feb;101(3):391.

36.

Lipid-coated nano-calcium-phosphate (LNCP) for gene delivery.

Zhou C, Yu B, Yang X, Huo T, Lee LJ, Barth RF, Lee RJ.

Int J Pharm. 2010 Jun 15;392(1-2):201-8. doi: 10.1016/j.ijpharm.2010.03.012. Epub 2010 Mar 7.

37.

Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors.

Rousseau J, Barth RF, Fernandez M, Adam JF, Balosso J, Estève F, Elleaume H.

J Neurooncol. 2010 Jul;98(3):287-95. doi: 10.1007/s11060-009-0074-3. Epub 2009 Dec 11.

38.

Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.

Yang W, Barth RF, Wu G, Huo T, Tjarks W, Ciesielski M, Fenstermaker RA, Ross BD, Wikstrand CJ, Riley KJ, Binns PJ.

J Neurooncol. 2009 Dec;95(3):355-365. doi: 10.1007/s11060-009-9945-x. Epub 2009 Jul 9.

39.

Intracerebral delivery of 5-iodo-2'-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma.

Rousseau J, Adam JF, Deman P, Wu TD, Guerquin-Kern JL, Gouget B, Barth RF, Estève F, Elleaume H.

J Synchrotron Radiat. 2009 Jul;16(Pt 4):573-81. doi: 10.1107/S0909049509016987. Epub 2009 May 28.

40.

Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.

Yang W, Barth RF, Wu G, Tjarks W, Binns P, Riley K.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S328-31. doi: 10.1016/j.apradiso.2009.03.030. Epub 2009 Mar 27.

PMID:
19467880
41.

Boron neutron capture therapy at the crossroads: challenges and opportunities.

Barth RF.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S3-6. doi: 10.1016/j.apradiso.2009.03.102. Epub 2009 Apr 1. Review.

PMID:
19467879
42.

High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide.

Christoforidis GA, Yang M, Kontzialis MS, Larson DG, Abduljalil A, Basso M, Yang W, Ray-Chaudhury A, Heverhagen J, Knopp MV, Barth RF.

Invest Radiol. 2009 Jul;44(7):375-83. doi: 10.1097/RLI.0b013e3181a8afea.

43.

Thirteenth International Congress on Neutron Capture Therapy.

Altieri S, Bortolussi S, Barth RF, Roveda L, Zonta A.

Appl Radiat Isot. 2009 Jul;67(7-8 Suppl):S1-2. doi: 10.1016/j.apradiso.2009.03.009. Epub 2009 Mar 24. No abstract available.

PMID:
19395267
44.

Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Barth RF, Kaur B.

J Neurooncol. 2009 Sep;94(3):299-312. doi: 10.1007/s11060-009-9875-7. Epub 2009 Apr 21. Review.

45.

Efficacy of intracerebral delivery of Carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats.

Rousseau J, Barth RF, Moeschberger ML, Elleaume H.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):530-6. doi: 10.1016/j.ijrobp.2008.09.018.

46.

Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors.

Barth RF, Yang W, Wu G, Swindall M, Byun Y, Narayanasamy S, Tjarks W, Tordoff K, Moeschberger ML, Eriksson S, Binns PJ, Riley KJ.

Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17493-7. doi: 10.1073/pnas.0809569105. Epub 2008 Nov 3.

47.

Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.

Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2008 Feb 1;14(3):883-91. doi: 10.1158/1078-0432.CCR-07-1968.

48.

Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).

Chandra S, Tjarks W, Lorey DR 2nd, Barth RF.

J Microsc. 2008 Jan;229(Pt 1):92-103. doi: 10.1111/j.1365-2818.2007.01869.x.

49.

Carboranyl thymidine analogues for neutron capture therapy.

Tjarks W, Tiwari R, Byun Y, Narayanasamy S, Barth RF.

Chem Commun (Camb). 2007 Dec 21;(47):4978-91. Epub 2007 Aug 15. Review.

PMID:
18049729
50.

Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation.

Rousseau J, Boudou C, Barth RF, Balosso J, Estève F, Elleaume H.

Clin Cancer Res. 2007 Sep 1;13(17):5195-201. Epub 2007 Aug 28.

Supplemental Content

Loading ...
Support Center